Targeted RNAi of BIRC5/Survivin Using Antibody-Conjugated Poly(Propylene Imine)-Based Polyplexes Inhibits Growth of PSCA-Positive Tumors
Delivery of siRNAs for the treatment of tumors critically depends on the development of efficient nucleic acid carrier systems. The complexation of dendritic polymers (dendrimers) results in nanoparticles, called dendriplexes, that protect siRNA from degradation and mediate non-specific cellular upt...
Saved in:
Main Authors: | Willi Jugel (Author), Achim Aigner (Author), Susanne Michen (Author), Alexander Hagstotz (Author), Alexander Ewe (Author), Dietmar Appelhans (Author), Gabriele Schackert (Author), Achim Temme (Author), Stefanie Tietze (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeted CRM197-PEG-PEI/siRNA Complexes for Therapeutic RNAi in Glioblastoma
by: Achim Aigner, et al.
Published: (2011) -
BIRC7 is Beneficial for Melanoma Progression and Hypoxic Response
by: Xu H, et al.
Published: (2022) -
PSCA is a target of chimeric antigen receptor T cells in gastric cancer
by: Di Wu, et al.
Published: (2020) -
PSCA rs2294008 C > T polymorphism contributes to gastric and bladder cancer risk
by: Wang M, et al.
Published: (2015) -
Drug Delivery by Ultrasound-Responsive Nanocarriers for Cancer Treatment
by: Kristin Entzian, et al.
Published: (2021)